Therapeutic monitoring
Digoxin concentrations: check when the sample was taken
A number reported by the laboratory is not automatically a clinically comparable number. Digoxin distributes into tissue after a dose. Sample timing, symptoms and kidney function affect what a concentration can tell you.
Sources checked October 6, 2026. Independent educational content, not NABP exam questions or individual treatment advice.
Protect the sampling interval
Record dose and draw times. The label recommends a predose sample or one taken at least six hours after the dose; a result obtained two hours after administration should not be treated as the same measurement.
Compare results taken at consistent times where possible. The label notes differences even between later postdose and predose samples. A trend can be misleading when the collection schedule changes silently.
Read symptoms alongside the concentration
The label identifies nausea, vomiting, anorexia and fatigue among toxicity symptoms and describes many possible cardiac arrhythmias. A concerning clinical presentation needs assessment even before a perfect repeat sample is available.
Do not declare a patient safe because one result looks familiar or because the dose has not changed. The monitoring question includes the patient, not only the concentration printed on the page.
Review kidney function and electrolytes
Digoxin dosing and toxicity risk depend on renal function and other clinical factors. The full label also discusses electrolyte abnormalities and interactions that can influence toxicity.
Recover current kidney function, potassium and the medication list rather than importing assumptions from an old visit. A new medicine or an acute illness may explain why a previously tolerated regimen now needs review.
Do not invent a replacement dose
A mistimed sample means interpretation is limited; it does not automatically mean toxicity, nor does it prove that the prescription should be reduced. Separate urgent assessment of symptoms from planning a correctly timed measurement.
This exercise does not provide an individual target concentration, dose-conversion rule or overdose treatment protocol. Its purpose is to prevent an isolated, poorly timed result from driving an unsupported treatment decision.
A worked case
A patient takes digoxin at 8 am and has blood drawn at 10 am. They report new nausea and dizziness after an illness, and the current renal function is not available. What is the better response than adjusting the dose from that result alone?
- Document that the sample is two hours after dosing, earlier than the cited label's at-least-six-hour interval.
- Assess current symptoms promptly and recover renal function, electrolytes and interactions.
- Plan further interpretation and appropriately timed testing through the clinical team, without waiting to assess a symptomatic patient.
Answer: Timing limits the number, while symptoms and missing current clinical data require assessment.
Try it before reading the answer
Write the key fact, decision and safety check first. These are original practice exercises, not recalled exam items.
1. Is a two-hour postdose sample the cited recommended sample?
No. The label calls for predose or at least six hours after the last dose.
2. Does a mistimed sample prove toxicity?
No. It limits interpretation; assess the clinical presentation and other data.
3. Should symptoms wait for a correctly timed repeat concentration?
No. Concerning symptoms need prompt clinical assessment.
Continue learning
Put the topic into a study planSources and scope
Source dates and limits matter. Follow the current official source for clinical or regulatory decisions. Examples are simplified teaching cases, not prescribing, diagnostic or compounding instructions. Check the full current guidance and individual clinical context.